Bloomberg @business
The FDA chief faces questions from a top lawmaker about the agency’s response to a report that UK drugmaker GSK hid and downplayed cancer risks from Zantac, its blockbuster heartburn drug, for four decades https://t.co/Xw3zRxTPiT — PolitiTweet.org